- Home
- PRZO vs RNXT Comparison
PRZO vs RNXT Comparison
Compare PRZO & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- RNXT
- Stock Information
- Founded
- PRZO 2014
- RNXT 2012
- Country
- PRZO Israel
- RNXT United States
- Employees
- PRZO N/A
- RNXT N/A
- Industry
- PRZO
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- PRZO
- RNXT Health Care
- Exchange
- PRZO Nasdaq
- RNXT Nasdaq
- Market Cap
- PRZO 32.3M
- RNXT 35.2M
- IPO Year
- PRZO 2023
- RNXT 2021
- Fundamental
- Price
- PRZO $1.40
- RNXT $0.80
- Analyst Decision
- PRZO
- RNXT Strong Buy
- Analyst Count
- PRZO 0
- RNXT 2
- Target Price
- PRZO N/A
- RNXT $7.50
- AVG Volume (30 Days)
- PRZO 966.5K
- RNXT 384.7K
- Earning Date
- PRZO 08-28-2025
- RNXT 11-13-2025
- Dividend Yield
- PRZO N/A
- RNXT N/A
- EPS Growth
- PRZO N/A
- RNXT N/A
- EPS
- PRZO N/A
- RNXT N/A
- Revenue
- PRZO $1,007,440.00
- RNXT $928,000.00
- Revenue This Year
- PRZO N/A
- RNXT $2,895.35
- Revenue Next Year
- PRZO N/A
- RNXT $313.04
- P/E Ratio
- PRZO N/A
- RNXT N/A
- Revenue Growth
- PRZO 80.42
- RNXT N/A
- 52 Week Low
- PRZO $0.53
- RNXT $0.70
- 52 Week High
- PRZO $3.16
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- PRZO 49.38
- RNXT 34.59
- Support Level
- PRZO $1.16
- RNXT $0.70
- Resistance Level
- PRZO $1.31
- RNXT $1.09
- Average True Range (ATR)
- PRZO 0.09
- RNXT 0.09
- MACD
- PRZO 0.01
- RNXT -0.03
- Stochastic Oscillator
- PRZO 71.79
- RNXT 19.22
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.